Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes.

MLA

Guma, Monica, et al. “Xanthine Oxidase Inhibitor Urate-Lowering Therapy Titration to Target Decreases Serum Free Fatty Acids in Gout and Suppresses Lipolysis by Adipocytes.” Arthritis Research & Therapy, vol. 24, no. 1, July 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13075-022-02852-4.

APA

Guma, M., Dadpey, B., Coras, R., Mikuls, T. R., Hamilton, B., Quehenberger, O., Thorisdottir, H., Bittleman, D., Lauro, K., Reilly, S. M., Liu-Bryan, R., & Terkeltaub, R. (2022). Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes. Arthritis Research & Therapy, 24(1), 1–13. https://doi.org/10.1186/s13075-022-02852-4

Chicago

Guma, Monica, Benyamin Dadpey, Roxana Coras, Ted R. Mikuls, Bartlett Hamilton, Oswald Quehenberger, Hilda Thorisdottir, et al. 2022. “Xanthine Oxidase Inhibitor Urate-Lowering Therapy Titration to Target Decreases Serum Free Fatty Acids in Gout and Suppresses Lipolysis by Adipocytes.” Arthritis Research & Therapy 24 (1): 1–13. doi:10.1186/s13075-022-02852-4.